All stocks / SMNR
Semnur Pharmaceuticals, Inc. SMNR
Semnur Pharmaceuticals (SMNR): convertible notes mentioned in an 8-K in March 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- SEMNUR PHARMACEUTICALS INC
- Market tier
- OTC Pink Limited
- Trading status
- Active
- Last trade
- 09:38:00
- Website
- semnurpharma.com/
News headlines
The financial report, and what it means
Annual figures to 2025-12-31- Net loss
- ($160,416,000)
It spends more than it earns
Under strainThe company lost $160.4 million in the year. It reported no sales.
- Cash and cash equivalents
- $20,000
- Net cash used in operating activities
- ($5,867,000)
The cash could run out soon
Under strainIt had $20,000 in the bank and used about $488,917 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.
- Total assets
- $1,346,000
- Total liabilities
- $22,096,000
It owes more than it owns
Under strainEverything the company owns adds up to $1.3 million. Its debts and unpaid bills add up to $22.1 million. That is about $16.42 owed for every $1 owned.
What this adds up to
3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 42,939,030 shares as of 2026-11-04: 217,709,142 outstanding minus 174,770,112 held by 1 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
8-K filed 2026-03-17 mentions: convertible note.
Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about SMNR
Does SMNR file reports with the SEC?
Yes. Semnur Pharmaceuticals files with the SEC under company number 0001913577. The most recent filing we hold is a 10-Q dated 2026-11-04.
Source recordHow many SMNR shares are outstanding?
217,709,142 shares as of 2026-11-04, as reported to the SEC.
Source recordHas SMNR filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Is Semnur Pharmaceuticals making money?
The company lost $160.4 million in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record